These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 33296271)
21. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366 [TBL] [Abstract][Full Text] [Related]
22. HIV-negative male couples' attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement. Mitchell JW; Lee JY; Woodyatt C; Bauermeister J; Sullivan P; Stephenson R AIDS Care; 2016 Aug; 28(8):994-9. PubMed ID: 27055001 [TBL] [Abstract][Full Text] [Related]
23. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B; Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043 [TBL] [Abstract][Full Text] [Related]
24. Rapid Uptake of Pre-Exposure Prophylaxis After Significant Price Reduction in Germany Highlights Importance of Pre-Exposure Prophylaxis Accessibility. Mysior P; Tenberken E; Stecher M; Vehreschild JJ; Schafberger A; Perea I; Brillen AL; Bartmeyer B; Esser S; Bremer V; Marcus U; Hoffmann D; Streeck H AIDS Res Hum Retroviruses; 2020 Sep; 36(9):721-733. PubMed ID: 32164425 [TBL] [Abstract][Full Text] [Related]
25. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C; BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533 [TBL] [Abstract][Full Text] [Related]
26. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
27. Early experience of implementing a national HIV pre-exposure prophylaxis service in Wales, United Kingdom 2017. Fina L; Phillips AL; Jones AT; Couzens ZM; Drayton R; Thomas DR; Shankar AG Sex Health; 2019 Feb; 16(1):56-62. PubMed ID: 30501846 [TBL] [Abstract][Full Text] [Related]
28. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331 [TBL] [Abstract][Full Text] [Related]
29. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG; Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098 [TBL] [Abstract][Full Text] [Related]
30. Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis. Stelzle D; Godfrey-Faussett P; Jia C; Amiesimaka O; Mahy M; Castor D; Hodges-Mameletzis I; Chitembo L; Baggaley R; Dalal S PLoS Med; 2021 Jan; 18(1):e1003482. PubMed ID: 33428611 [TBL] [Abstract][Full Text] [Related]
31. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming. Hillis A; Germain J; Hope V; McVeigh J; Van Hout MC AIDS Behav; 2020 Nov; 24(11):3056-3070. PubMed ID: 32274670 [TBL] [Abstract][Full Text] [Related]
32. Pre-exposure Prophylaxis Awareness Among Gay and Other Men who have Sex with Men in Vancouver, British Columbia, Canada. Lachowsky NJ; Lin SY; Hull MW; Cui Z; Sereda P; Jollimore J; Rich A; Montaner JS; Roth EA; Hogg RS; Moore DM AIDS Behav; 2016 Jul; 20(7):1408-22. PubMed ID: 26884310 [TBL] [Abstract][Full Text] [Related]
33. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis. Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889 [TBL] [Abstract][Full Text] [Related]
34. High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda. Ssempijja V; Nakigozi G; Ssekubugu R; Kagaayi J; Kigozi G; Nalugoda F; Nantume B; Batte J; Kigozi G; Yeh PT; Nakawooya H; Serwadda D; Quinn TC; Gray RH; Wawer MJ; Grabowski KM; Chang LW; Van't Hoog A; Cobelens F; Reynolds SJ J Acquir Immune Defic Syndr; 2022 Jul; 90(3):291-299. PubMed ID: 35259129 [TBL] [Abstract][Full Text] [Related]
35. Are current guidelines adapted for patient eligibility to PrEP? A case report. Van Obberghen EK; Viard D; Lafeuillade A; Civiletti A; Rocher F; Drici MD BMC Infect Dis; 2019 Jul; 19(1):601. PubMed ID: 31291899 [TBL] [Abstract][Full Text] [Related]
36. Pre-Exposure Prophylaxis (PrEP) Use is Associated With Health Risk Behaviors Among Moderate- and Heavy-Drinking MSM. Luehring-Jones P; Palfai TP; Tahaney KD; Maisto SA; Simons J AIDS Educ Prev; 2019 Oct; 31(5):452-462. PubMed ID: 31550196 [TBL] [Abstract][Full Text] [Related]
37. Different guidelines for pre-exposure prophylaxis (PrEP) eligibility estimate HIV risk differently: an incidence study in a cohort of HIV-negative men who have sex with men, Portugal, 2014-2018. Meireles P; Plankey M; Rocha M; Brito J; Mendão L; Barros H Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700673 [TBL] [Abstract][Full Text] [Related]
38. Which Patients in the Emergency Department Should Receive Preexposure Prophylaxis? Implementation of a Predictive Analytics Approach. Ridgway JP; Almirol EA; Bender A; Richardson A; Schmitt J; Friedman E; Lancki N; Leroux I; Pieroni N; Dehlin J; Schneider JA AIDS Patient Care STDS; 2018 May; 32(5):202-207. PubMed ID: 29672136 [TBL] [Abstract][Full Text] [Related]
39. Congruence between Hypothetical Willingness to Use Pre-Exposure Prophylaxis (PrEP) and Eligibility: An Online Survey among Belgian Men Having Sex with Men. Bullinger J; Reyniers T; Vuylsteke B; Laga M; Nöstlinger C Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31718012 [TBL] [Abstract][Full Text] [Related]
40. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK. O'Halloran C; Croxford S; Mohammed H; Gill ON; Hughes G; Fifer H; Allen H; Owen G; Nutland W; Delpech V; Saunders JM Sex Transm Infect; 2021 Sep; 97(6):429-433. PubMed ID: 33082235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]